Related Experiment Video
Updated: Jun 1, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression
Jung-Chien Cheng1, Hsun-Ming Chang, Peter C K Leung
1Department of Obstetrics and Gynecology, Child and Family Research Institute, University of British Columbia, 4490 Oak Street, Vancouver, British Columbia, Canada, V6H 3V5.
Abstract:
A major function of the p53 tumor suppressor is the regulation of the cell cycle and apoptosis. In addition to its well-documented functions in malignant cancer cells, p53 can also regulate cell migration and invasion, which contribute to metastasis. Growth differentiation factor-15 (GDF-15), a member of the TGF-β superfamily, has been shown to be a downstream target of p53 and is associated with diverse human diseases and cancer progression. In this study, we examined the potential role of GDF-15 in p53-regulated cancer cell motility. We show that overexpression of wild-type p53 in two highly invasive p53-null human cancer cell lines, SKOV3 and PC3, attenuated cell migration and the movement through Matrigel. Using wild-type p53 and DNA-binding-deficient p53 mutants, we found that the transcriptional activity of p53 is required in the induction of GDF-15 expression. Cell movement through uncoated and Matrigel-coated transwell decreased in response to treatment with recombinant GDF-15, whereas the cell proliferation was not affected by GDF-15 treatment. Moreover, the induction of GDF-15 expression and secretion by p53 and the reduction in cell movement through Matrigel were diminished by treatment with GDF-15 small interfering RNA. This study demonstrates a mechanism by which p53 attenuates cancer cell motility through GDF-15 expression. In addition, our results indicate that GDF-15 mediates the functions of p53 by autocrine/paracrine action.
Insights
The tumor suppressor p53 inhibits cancer cell migration and invasion by inducing Growth Differentiation Factor-15 (GDF-15) expression. GDF-15 mediates this effect through autocrine/paracrine signaling, reducing cell motility without impacting proliferation.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The p53 tumor suppressor is crucial for cell cycle regulation and apoptosis.
- p53 also influences cancer cell migration, invasion, and metastasis.
- Growth Differentiation Factor-15 (GDF-15) is a TGF-β superfamily member, a p53 target, and implicated in cancer progression.
Purpose of the Study:
- To investigate the role of GDF-15 in p53-mediated cancer cell motility.
- To elucidate the mechanism by which p53 regulates cancer cell movement.
Main Methods:
- Overexpression of wild-type p53 in p53-null cancer cell lines (SKOV3, PC3).
- Assessment of cell migration and Matrigel invasion assays.
- Utilized wild-type p53 and DNA-binding-deficient mutants to study transcriptional activity.
- Treatment with recombinant GDF-15 and GDF-15 small interfering RNA (siRNA).
Main Results:
- Wild-type p53 overexpression attenuated cancer cell migration and Matrigel invasion.
- p53's transcriptional activity is essential for inducing GDF-15 expression.
- Recombinant GDF-15 reduced cell movement but did not affect proliferation.
- GDF-15 siRNA diminished p53-induced GDF-15 expression and reduced cell motility.
Conclusions:
- p53 attenuates cancer cell motility through the induction of GDF-15 expression.
- GDF-15 acts via autocrine/paracrine signaling to mediate p53's effects on cell motility.
- This pathway represents a novel mechanism for p53 in controlling cancer metastasis.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

